Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Qin-Guo Mo, De-Quan Li, Jian-Hong Zhong & Chang-Yuan Wei. (2016) Are another 5 years of adjuvant aromatase inhibitor therapy needed?. Breast Cancer: Targets and Therapy 8, pages 207-209.
Read now
Read now
Articles from other publishers (4)
Yuan Peng, Taobo Hu, Lin Cheng, Fuzhong Tong, Yingming Cao, Peng Liu, Bo Zhou, Miao Liu, Hongjun Liu, Jiajia Guo, Fei Xie, Houpu Yang, Siyuan Wang, Chaobin Wang & Shu Wang. (2021) Evaluating and Balancing the Risk of Breast Cancer-Specific Death and Other Cause-Specific Death in Elderly Breast Cancer Patients. Frontiers in Oncology 11.
Crossref
Crossref
Xin Li & Hyungju Kwon. (2019) Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Elderly Patients with Metastatic Breast Cancer: A Meta-Analysis. Journal of Clinical Medicine 8:10, pages 1689.
Crossref
Crossref
T. Almodovar, E. Teixeira, A. Barroso, M. Soares, H.J. Queiroga, J. Cavaco-Silva & F. Barata. (2019) Elderly patients with advanced NSCLC: The value of geriatric evaluation and the feasibility of CGA alternatives in predicting chemotherapy toxicity. Pulmonology 25:1, pages 40-50.
Crossref
Crossref
Suk-young Lee & Jae Hong Seo. (2018) Current Strategies of Endocrine Therapy in Elderly Patients with Breast Cancer. BioMed Research International 2018, pages 1-12.
Crossref
Crossref